Protocol Ledger

NCT05212246 · Phase III · RECRUITING

Basal Cell Carcinoma Chemoprevention Trial

Interventional Phase III clinical trial protocol NCT05212246 sponsored by VA Office of Research and Development in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-10-06 Enrollment: 1,630 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT05212246
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)1,630 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05212246
Protocol FieldVerified Registry Value
NCT IdentifierNCT05212246
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase III
Overall Recruitment StatusRECRUITING
Registered Enrollment1,630 participants (ESTIMATED)
Registered Start Date2026-10-06
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI